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Featured Article
In this month’s newsletter, Dr Mohammad Firdaus
Abdul Aziz highlights the promising benefits of
stem cell-based therapy to cure many kinds of
diseases and the importance of the general public
to be aware of the current development of this 21st
century medical technology. 
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A special note to thank the outgoing Director
of CELEST and to welcome our new director.
It is less than 3 years since the inaugural CELEST Newsletter was published. In that short time,
frame we have published 11 articles on various topical topics based on the real-world issues
related to law and ethics in the science and technology domain. We are indeed proud of this
achievement.
I must say that we are indebted to Associate Prof Dr Tay Pek San, the outgoing Director of
CELEST. She has recently retired from her teaching position at the Faculty of Law. On behalf
of the CELEST member, I would like to thank her for the enormous time and effort that she
has invested in laying the foundation of CELEST and the immensely valuable contribution in
steering the direction of the centre. Since its inception, Dr Tay Pek San has encouraged its
growth including the instigation of the publication of this newsletter. We wish her all the
best for her next endeavor and look forward to continue working with her. 
I am pleased to announce that Dr Sharon Kaur, has now been appointed by the faculty as the
new Director of CELEST. She is a senior lecturer at the Faculty of Law. She has a vast
experience in the field of medical law, medical ethics, and research ethics. Through her wide
network both at local and international level, we  believe the centre can go to the next level
under her leadership  and we are very much looking forward to working together with her at
the helm. 
Also, we are grateful for the support from the faculty and the CELEST members . We will
continue working to make CELEST a thriving centre for research excellence relating to legal
and ethical aspect of science and technology and its newsletter an academically useful that
you look forward to reading each quarter. 
Respectfully,
Mohammad Firdaus Abdul Aziz, DPhil
Senior Lecturer,
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Pardis Moslemzadeh Tehrani (2020). States
Obligations to Impose Emergency Measures





Akbariavaz, Khalil, and Pardis
Moslemzadeh Tehrani (2020). "The Role of
International Law in Protection against
Attacks on Children's Education Rights in
Armed Conflict." J. Pol. &
L. 13: 90.
Osama Ismail Mohammad Amayreh, Izura
Masdina Mohamad Zakri, Pardis
Moslemzadeh Tehrani & Yousef
Mohammad Shadi (2020). The Pre-
Contractual Obligation to Confidentiality of
Information in the Palestinian Civil Code
Draft and its Role in Maintaining Economic
Contractual Equilibrium. UUM Journal of
Legal Studies, vol 10(2), pp. 121-156 ISSN:
01279483
Book
Tay Pek San, Intellectual Property Law in
Malaysia (2nd ed.) Thomson Reuters (Sweet
and Maxwell). Scheduled for release at the
end of October 2020.
Chapter in books
Maryam Khalid & Sherin Kunhibava (2020).
Regulating FinTech Through Sandboxes:
Entering the UK and Malaysian Regulatory
Sandbox. In Albastaki, Y.A., Razzaque,
A., and Sarea, A.M., (Eds), Innovative
Strategies for Implementing FinTech in
Banking, pp. 83-99, Hershey, PA: IGI Global.
ISBN: 1799832570
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Congratulations to our members on the
following:
Appointments
Dr Pardis Moslemzadeh Tehrani was
appointed as a member of
the Editorial Review Board of International
Journal of Digital Crime and Forensics.
Dr Pardis Moslemzadeh Tehrani was
appointed as an Ad hoc Editorial
Review Board of International Journal of
Digital Crime and Forensics
(IJDCF).
Dr Mohammad Firdaus Abdul Aziz was
appointed as an external reviewer for LLM
(Healthcare and Medical Law) Program at
Taylor's University.
Dr Mohammad Firdaus Abdul Aziz was
appointed as external supervisor for LLM
(Medical Ethics and Law) at the University of
Hong Kong.
Dr Mohammad Firdaus Abdul Aziz was
appointed as a reviewer for the Journal of
Science and Engineering Ethics
Dr Sharon Kaur was appointed as a member
of the Ethics Advisory Council of the
International COVID-19 Data Research
Alliance
Articles 
Maryam Khalid & Sherin Kunhibava (2020).
Fintech Regulatory Sandboxes in Australia
and Malaysia: A Legal Analysis. IIUM Law
Journal,vol 28(1), pp. 1-35.
News
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Dr Pardis Moslemzadeh Tehrani served as a
Chair at the 19th European Conference on
Cyber Warfare and Security, organized by
the University of Chester, United Kingdom.
 
Dr Pardis Moslemzadeh Tehrani spoke on
“Teaching International Law in the Online
Classroom: Challenges and Strategies” at the
workshop entitled “Teaching
International Law: New Strategies to Meet
the Challenges of a Dynamic Subject”,
organized by Multimedia University.
CELEST, in collaboration with Asia-Europe
Institute and the University of Malaya
Research Ethics Committee, organized a
webinar on ‘Digital Data in Social Science
Research: Legal and Ethical Concerns’. Our
researchers, Dr Izura Masdina
Mohammed Zakri and Dr Sik Cheng Peng,
spoke on ‘Privacy, data
protection and cyber security law’ and
‘Copyright law in the digital age’





18 September 2020 
30 September and 2 October 2020
Dr Sharon Kaur was a panelist in the
session on ‘Desirable developments and
possible solutions for a trustworthy
data governance’ at the experts online
workshop entitled ‘Towards trustworthy
data governance for healthcare
technologies’. The webinar is inscribed
within the Future of Health
Technologies (FHT) project, a collaboration
between ETH Zurich and the National
University of Singapore.
 
Dr Pardis Moslemzadeh Tehrani presented
an article at The 16th ALIN General Meeting
& International Conference, Laws for Fading
Borders in Asia, entitled"Regulatory
Compliance and  Data Protection in Contact
Tracing Applications under COVID-19".
 
Dr Sharon Kaur spoke on ‘Living Wills in
Malaysia’ at the ‘Living Will, Living
Well? Advance Directives Across Asia’
workshop organized by the University of
Hong Kong.
What do you know about stem cell research and
therapy?
By Dr Mohammad Firdaus Abdul Aziz
Faculty of Law, Universiti Malaya
Author's Biography
Dr Mohammad Firdaus is a senior lecturer at the Faculty of Law, Universiti
Malaya. He is also an academic affi l iate at the Centre for Health, Law and
Emerging Technologies (HeLEX), Faculty of Law at the University of Oxford.
He teaches Medical Law and Ethics and Law and Society at undergraduate
level and Healthcare Law and Ethics, Biosafety Law, and Biodiversity Law at
postgraduate level. He also teaches Ethical Issues of Emerging Sciences for
Master in Health Research Ethics program at the Faculty of Medicine. He is
currently researching on the regulation and policy of various emerging
technologies such as biobanking, stem cell research and therapy,
genetically modified organism as well as supervising research work on
abortion law, juvenile criminal justice, and medical treatment for severely
impaired neonates. He is also a self-taught artist and his artworks have




Stem cell research and therapy has become a
global phenomenon given the potential
use of stem cells to develop therapies to cure
degenerative diseases that are incurable by
conventional medicine. This is due to the
unique ability that stem cells have to
differentiate into the various cell types of the
body while at the same time replicating to
maintain stem cells pool in the body.
There are different forms or types of stem cells
that exist in our body such as embryonic stem
cells and adult stem cells and each type of
these stem cells have varying capacity and
potency to replicate and differentiate into
different cell types that form tissues and
organs. Due to its unique ability, stem cells
have been used for research purposes in the
effort to develop treatment.
Given its promising benefits, there are many
clinics across the globe leveraging on the
‘hype’ of stem cells by offering and
marketing stem cell therapies [1]. These clinics
are offering many different kinds of treatments
for a wide range of diseases and medical
conditions. The treatment can be purchased
via the Internet [2].
Many of these clinics not only exist in the
developed countries such as the USA, Japan,
Australia, a few European countries such as
Italy and Germany, but also in the newly
emerging industrialised countries such as
China, India, and Mexico. The escalating claim
over the benefits of stem cell therapies have
attracted increased attention among patients
who are desperately looking for a cure, which
has led to the phenomenon known as ‘stem
cell tourism’, whereby these patients travel
from their home country to another country




Unfortunately, most of these ‘therapies’ lack
testing of efficacy and safety. Therefore, this
phenomenon gives rise to concerns over the
risky situation that these patients may put
themselves into as well as their financial and
emotional wellbeing.
Stem cell research and application in
Malaysia
Malaysia also recognises the importance of
this highly promising medical technology. The
Academy Sciences of Malaysia commissioned
a Task Force to prepare a report about the
development of research activities involving
stem cells and therapy in Malaysia, which was
published in 2009.
It is highlighted in the report that Malaysia
sought to venture into this field for two main
reasons namely (i) the potential use of cell
therapy to address diseases of a rapidly
growing population of ageing citizens in the
country and (ii) cell therapy can also be
leveraged on to promote national
development goals especially the commercial
aspects. Based on the report, there are quite a
number of researchers in the public sector
mainly from public universities and
government research agencies who are
carrying out research work in this field.
However, it has been 11 years since the report
was published and to date, there is no
updated data about the current state-of-art
and capacity in developing this field in
Malaysia.  Also, little is known about the
activities in the private sector [4].
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...due to the unique ability that stem cells have to
differentiate into the various cell types of the body
while at the same time replicating to maintain stem
cells pool in the body...Given its promising benefits,
there are many clinics across the globe leveraging
on the ‘hype’ of stem cells by offering and
marketing stem cell therapies. These clinics are
offering many different kinds of treatments for a wide
range of diseases and medical conditions.
Another example of a successful stem cell-
based therapy is the case reported in 2016
involving a one-year old boy, Muhammad
Yusuff, who was suffering from a severe lung
infection and not having immune system,
which is a very rare case known as ‘bubble
boy disease’. His condition was cured using
bone marrow stem cells transplanted from his
father. The procedure took place at the
University Malaya Medical Centre (UMMC) [6].
Malaysia is also a host for quite a number of
foreign companies that offer stem cell
therapies for many other medical conditions.
An empirical study in 2012 showed that there
are concerns among key stakeholders (policy
makers, stem cell researchers, ethicists) in
Malaysia given the increasing number of
clinics providing stem cell therapies which are
not known of its effectiveness [7]. 
Some of the concerns highlighted in the
study include the level of knowledge and
awareness among the members of the public;
whether or not they are well informed about
the technology and ‘therapy’ they receive.
Also, the stakeholders are worried in case of
any unfortunate events, the reputation of this





Institute of Medical Research (IMR) and National
Cancer Council (MAKNA) has founded the
Malaysia Stem Cell Registry in 2020. The registry
acts as a database of volunteers who are potential
stem cells donors...Since its inception, there are a
number of successful cases of stem cell therapy
reported in the country. However, this initiative is
currently confined to blood disorder.
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In terms of the application of stem cell
therapy in Malaysia, the government
through the collaboration between Institute
of Medical Research (IMR) and National
Cancer Council (MAKNA) has founded the
Malaysia Stem Cell Registry in 2020. The
registry acts as a database of volunteers who
are potential stem cells donors. The registry
plays an important role to match potential
donors with patients who need stem cell
transplants. Since its inception, there are a
number of successful cases of stem cell
therapy reported in the country. However, this
initiative is currently confined to blood
disorder. Nonetheless, one could see that
there is a possibility that the scope of the
registry could be expanded to include other
diseases in the future.
On September 30th, 2019, The Star reported a
celebration of a two-time stem cell donor,
Zahari Mansur, who donated his bone marrow
stem cells (from his blood) to both his sisters,
Zabiha and Zawiah on two different
occasions. Zabiha was the recipient of Zahari’s
stem cells in 2009 after he was identified by
Ampang Hospital as a suitable donor to save
his sister who was suffering from
myelofibrosis. His bone marrow stem cells
were used to help regenerate his sister’s bone
marrow. One year later, he once again called
up to save another sister of his, Zawiah who
had acute myeloid leukemia [5]. 
Regulation in Malaysia
Malaysia has yet to introduce legislation that
is primarily regulating stem cell research and
therapy. Currently, it can be said that stem
cell research and therapy is under-regulated.
In the absence of specific legislation, this field
is presently regulated through guiding rules,
namely the National Guidelines for Stem Cell
Research and Therapy which was issued in
2006 and later revised in 2009 [9,10]. 
In general, these guidelines are non-binding
in nature and arguably less effective to be
comprehensively enforced across the board.
The scope of these guidelines is rather limited
to research and therapy that involves
government staff and facilities, and work on
human subjects. It is unclear as to how
entities in the private sector are being
regulated. 
Apart from these guidelines, there are also
other circulars and guidelines introduced by
the medical council specifically for licensed
medical practitioners who are involved in this
field, which have legal mandate and can be
imposed on medical practitioners in Malaysia.
In addition, medical interventions involving
stem cells in the private clinical setting
carried out by licensed medical practitioners
can be subject to the umbrella act governing
private practice, which is the Private
Healthcare Facilities and Services Act 1998.
Nonetheless, in 2017, the then Minister of
Health, Datuk Seri Dr S. Subramaniam urged
Malaysians to be cautious in making their
decision if they consider to undergo
any stem cell-based therapy. He made it clear
that the application of stem cells in Malaysia
is limited to certain medical conditions.
According to him, the general public need to
be cautious of stem cell therapies that are
being offered to treat different kinds of
medical conditions that have not been
approved by mainstream science [11].
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In view of the proliferation of stem cell
therapies being offered in the country,
there is an urgent need to revisit the current
regulatory framework in Malaysia [12,13]. One
can argue that Malaysia should consider
enacting a specific legislation to regulate
this promising field, which may take some
time to materialise. Another option, which
could be a faster route would be to amend
the existing relevant acts such as the Human
Tissue Act 1974 to incorporate stem cells and
its revolutionary therapies.
Will regulation obstruct the
development of stem cell therapy?
It must be pointed out that the role of
regulation is not to hamper development of
this technology and to impose unnecessary
obstacles on businesses to commercialise
stem cell therapy. Regulation is vital
to ensure that this technology is applied
ethically and safeguard public safety
as well as to protect the reputation of this
revolutionary field. This is demonstrated by
many countries that have heavily invested in
developing stem cell research legitimate
therapies, they have also established
regulation to ensure translational research
from bench to bedside is appropriately
governed and overseen [14].
In view of the proliferation of stem cell therapies being
offered in the country, there is an urgent need to revisit
the current regulatory framework in
Malaysia...Regulation is vital to ensure that this
technology is applied ethically and safeguard public
safety as well as to protect the reputation of this
revolutionary field.
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However, there is a risk of hampering the
development if the regulation is not
carefully designed and can cause a
bureaucratic system and disconnection
with what is happening in the real world. It
can be argued that if Malaysia aspired to
join the leading countries in this field such
as the UK, Japan, and South Korea, it
is important for us to learn from these
countries in establishing a regulatory
framework that can facilitate ethical
development. Having an established
regulation is also important to secure
public trust. Public trust is vital and
without which it may affect public funding.
To secure public trust, measures to
safeguard the public from being
manipulated and deceived by bogus stem
cell providers are crucial and need to be
incorporated in the regulation.
Public awareness
The issue of lack of awareness among the
public has been widely discussed by
scholars. A few studies have been carried
out to find out the level of awareness
among the general public in many
countries. For instance, a study in
Japan was reported in 2006 demonstrating
that not many Japanese are aware of
stem cells even after the ground-breaking
news of the discovery of induced-
pluripotent stem cells by a world-renowned
Japanese scientist, Shinya Yamanaka that
was thought could potentially replace the
use of the ethically controversial human
embryonic stem cells [15}. One could
question if the general public in one of the
leading nations in stem cell research has
lack of awareness, what about the level of
awareness in lower- and middle-income
countries such as Malaysia? As mentioned
earlier, an empirical study in 2012
highlighted the concerns among
the stakeholders over the level of awareness
among Malaysian public amidst the
proliferation of stem cell therapies being
offered in the country [16].
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One could question if the general public in one of the
leading nations in stem cell research has lack of
awareness, what about the level of awareness in
lower- and middle-income countries such as
Malaysia?
In view of this situation, a group of
researchers is conducting an online survey to
find out the level of the general public’s
understanding on stem cell research and
therapy and to explore whether or not the
general public has access to information on
the existing stem cell treatment offered by
both local and foreign companies in the
country. It is hoped that through this study, a
more effective regulatory system can be
explored to facilitate the members of the
public to better understand stem cell
research and therapy and be able to make
informed decisions before undergoing stem
cell therapies.
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Thank you to Dr Sharon Kaur for 
15. Sleeboom-Faulkner, M. (2011). Regulating
cell lives in Japan: avoiding scandal and
sticking to nature. New Genetics and Society,
30(3), 227-240.
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